Arcturus Therapeutics Holdings Inc. Company Profile
NASDAQ: ARCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Arcturus Therapeutics at a glance
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in San Diego, CA, Israel. Arcturus Therapeutics is led by Mr. Joseph E. Payne M.Sc. and employs about 106 people. The company's shares have traded publicly since 2013.
At a market capitalization of $214.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001768224, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Arcturus Therapeutics do?
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
Business description based on the company's public filings.
Company information
- Legal name
- Arcturus Therapeutics Holdings Inc.
- Ticker
- NASDAQ: ARCT
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Joseph E. Payne M.Sc.
- Employees
- 106
- Headquarters
- 10285 Science Center Drive, San Diego, CA, Israel
- Phone
- 858 900 2660
- Website
- arcturusrx.com
- IPO year
- 2013
- Market cap
- $214.73M
- SEC CIK
- 0001768224
- Latest annual report
- 10-K · Mar 3, 2026
Companies similar to Arcturus Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PYXSPyxis Oncology Inc. | 1.81 | +7.74% | $216.49M | vs ARCT |
| KROSKeros Therapeutics Inc. | 11.08 | -2.72% | $217.44M | vs ARCT |
| RCKTRocket Pharmaceuticals Inc. | 1.95 | -7.58% | $217.74M | vs ARCT |
| IMRXImmuneering Corporation Class A | 3.38 | -2.03% | $218.90M | vs ARCT |
| CYPHCypherpunk Technologies Inc. | 1.41 | -18.02% | $210.15M | vs ARCT |
| VNDAVanda Pharmaceuticals Inc. | 3.45 | -6.13% | $208.32M | vs ARCT |
| ENTAEnanta Pharmaceuticals Inc. | 7.62 | -4.51% | $222.19M | vs ARCT |
| FTHFaeth Therapeutics Inc. | 7.88 | -9.32% | $203.65M | vs ARCT |